Home › Funds › Frazier Life Sciences Management, L.P. › IMCR

Frazier Life Sciences Management, L.P. position in IMCR

IMMUNOCORE HLDGS PLC · Health Care

Frazier Life Sciences Management, L.P. reported holding 484,782 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q2 2026 13F filing — a position valued at US$15.4M, representing 0.34% of its reported portfolio and ranking #36 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed IMCR holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)484.78K sh
Reported value held$15.39M
Portfolio Weight0.34%
First reportedQ2 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s IMCR position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in IMCR in Q2 2024 at 108,762 shares (US$3.7M). The position peaked in Q2 2026 at 484,782 shares, worth US$15.4M. Across 9 filings, Frazier Life Sciences Management, L.P. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 484,782 shares valued at US$15.4M. Notable position changes include a 177% increase in Q1 2025 (shares rose 6% over the following quarter), a 28% increase in Q2 2025 (shares rose 16% over the following quarter), a 26% increase in Q1 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 108.76K $3.69M New
Q3 2024 108.76K $3.39M Hold
Q4 2024 108.76K $3.21M Hold
Q1 2025 301.17K $8.94M Add
Q2 2025 384.78K $12.07M Add
Q3 2025 384.78K $13.98M Hold
Q4 2025 384.78K $13.36M Hold
Q1 2026 484.78K $14.62M Add
Q2 2026 484.78K $15.39M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMCR and 13F data

IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 31 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$154.6M), Bellevue Group AG (US$88.5M), TANG CAPITAL MANAGEMENT LLC (US$84.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMCR

All IMCR fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held IMCR?

Frazier Life Sciences Management, L.P. has disclosed IMCR holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is Frazier Life Sciences Management, L.P.'s current position in IMCR?

As of Q2 2026, Frazier Life Sciences Management, L.P. holds 484.78K shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $15.39M, representing 0.34% of its reported portfolio and ranking #36.

Has Frazier Life Sciences Management, L.P. been buying or selling IMCR?

In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in IMCR. The position peaked in Q2 2026 at 484.78K shares.

Which other funds hold IMCR?

Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.